Literature DB >> 17563611

Lost productive time and costs due to diabetes and diabetic neuropathic pain in the US workforce.

Walter F Stewart1, Judith A Ricci, Elsbeth Chee, Annemarie G Hirsch, Nancy A Brandenburg.   

Abstract

OBJECTIVE: Estimate the impact of diabetes and neuropathic pain on the US workforce.
METHODS: Data on lost productive time (LPT) was collected by telephone interview in a random sample of the US population (N=36,634). Of 19,075 occupation-eligible working adults included in the analysis, 1003 reported a physician diagnosis of diabetes; 38% of these reported numbness or tingling in feet or hands due to diabetes (symptom group). We compared diabetes respondents with and without symptoms to other respondents for LPT and related cost.
RESULTS: Health-related LPT was 18% higher in the symptom (P<0.05) and 5% higher in the non-symptom (P<0.05) groups versus for those without diabetes. The symptom group lost 1.4 hours of work per week more than the non-symptom group (P<0.05).
CONCLUSIONS: Workers who have diabetes with neuropathic symptoms lose the equivalent of $3.65 billion/yr in health-related LPT.

Entities:  

Mesh:

Year:  2007        PMID: 17563611     DOI: 10.1097/JOM.0b013e318065b83a

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  26 in total

1.  Education and employment status of children and adults with thalassemia in North America.

Authors:  Zahra Pakbaz; Marsha Treadwell; Hae-Young Kim; Felicia Trachtenberg; Nagina Parmar; Janet L Kwiatkowski; Melody J Cunningham; Marie Martin; Nancy Sweeters; Ellis J Neufeld; Patricia J Giardina; Nancy Olivieri; Robert C Yamashita; Elliott Vichinsky
Journal:  Pediatr Blood Cancer       Date:  2010-10       Impact factor: 3.167

Review 2.  The need for knowledge translation in chronic pain.

Authors:  James L Henry
Journal:  Pain Res Manag       Date:  2008 Nov-Dec       Impact factor: 3.037

Review 3.  New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain.

Authors:  Eva L Feldman; Klaus-Armin Nave; Troels S Jensen; David L H Bennett
Journal:  Neuron       Date:  2017-03-22       Impact factor: 17.173

Review 4.  Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed - A Review for Primary Care.

Authors:  Michael T Sheehan
Journal:  Clin Med Res       Date:  2016-05-26

Review 5.  Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control.

Authors:  J R Miranda-Massari; M J Gonzalez; F J Jimenez; M Z Allende-Vigo; J Duconge
Journal:  Curr Clin Pharmacol       Date:  2011-11

6.  Altered excitation-inhibition balance in the brain of patients with diabetic neuropathy.

Authors:  Myria Petrou; Rodica Pop-Busui; Bradley R Foerster; Richard A Edden; Brian C Callaghan; Steve E Harte; Richard E Harris; Daniel J Clauw; Eva L Feldman
Journal:  Acad Radiol       Date:  2012-05       Impact factor: 3.173

7.  Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores.

Authors:  Ning Yan Gu; Chris Bell; Marc F Botteman; Xiang Ji; John A Carter; Ben van Hout
Journal:  Patient       Date:  2012       Impact factor: 3.883

8.  A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients.

Authors:  Luke Boulanger; Yang Zhao; Yanjun Bao; Mason W Russell
Journal:  BMC Health Serv Res       Date:  2009-06-30       Impact factor: 2.655

9.  Development of a Diabetes Mellitus Knowledge Resource for Clinical Decision Support Assisting Primary Care Physicians With Work-Related Issues.

Authors:  Anna Allen; Laura Welch; Katherine Kirkland; Douglas Trout; Sherry Baron
Journal:  J Occup Environ Med       Date:  2017-11       Impact factor: 2.162

Review 10.  A systematic review of the effectiveness of knowledge translation interventions for chronic noncancer pain management.

Authors:  Maria B Ospina; Paul Taenzer; Saifee Rashiq; Joy C MacDermid; Eloise Carr; Dagmara Chojecki; Christa Harstall; James L Henry
Journal:  Pain Res Manag       Date:  2013 Nov-Dec       Impact factor: 3.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.